Confounding and indication for treatment in evaluation of drug treatment for hypertension.
about
Adenotonsillectomy for upper respiratory infections: evidence based?The role of 'confounding by indication' in assessing the effect of quality of care on disease outcomes in general practice: results of a case-control studyThird generation oral contraceptives and risk of venous thrombosis: meta-analysisβ-Blockers and All-Cause Mortality in Adults with Episodes of Acute Bronchitis: An Observational StudyAre statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey.Tramadol and seizures: a surveillance study in a managed care population.Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studiesA modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid.Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey.Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia.Mental health service use after the World Trade Center disaster: utilization trends and comparative effectivenessStatins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.Insulin treatment and cardiovascular disease; friend or foe? A point of view.Pharmacogenetics of response to statins: where do we stand?Associations of commonly used medications with urinary incontinence in a community based sample.Common prescription medication use and erectile dysfunction: results from the Boston Area Community Health (BACH) survey.Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation - a cohort study from Sweden using propensity score analyses.Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010.Cautionary tales in the interpretation of studies of tools for predicting risk and prognosis.Implementing a collaborative protocol in a sepsis intervention program: lessons learned.Clinical depression, antidepressant use and risk of future cardiovascular disease.Sensitivity and specificity of fluorescence microlymphography for detecting lymphedema of the lower extremity.Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study.Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.Comparing outcomes of different treatment regimens for severe haemophilia.RCTs and observational studies to determine the effect of prophylaxis in severe haemophilia.Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.Prostate-selective α antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: a nationwide population-based study.Analysis of recruitment in a pragmatic observational study on C-reactive protein point-of-care testing in primary care.Confounding in publications of observational intervention studies.
P2860
Q24675039-6B88DFC5-4109-4A73-A901-0B731791B373Q24800184-60EA4E5E-42E1-4051-AA96-62959A4D51E4Q28344562-5D704321-8988-438A-BE5D-8CDFD712BDB4Q28533991-C61EB808-606F-46A1-9C79-B139687AB9CFQ30428005-47CD6361-E183-40F0-A0FC-F26B684E379AQ34113752-E9DF21C0-C0EE-45C6-BF0C-DA41BC3BDD2BQ34382106-7D28AF51-2FDF-453C-AA9D-10C7B863D7F7Q34658238-DEC03457-5722-4F43-A9D0-1AB90691622EQ34890523-99DFF426-9609-4415-B4F8-465AAF0E6872Q35013711-DF28B182-F45E-4C92-A538-E09C125E8D00Q35431110-E59813DE-6920-4948-8748-F8B4FC81E0C6Q35643437-06BD00FE-61E8-4B25-BBD7-25B2E40D0E06Q35685688-6723EC91-D146-4540-87C8-1BCCC11669B3Q35907465-AD2A9E92-7B12-468F-B4CC-37AAFC45680DQ36014026-5910E57A-EBCF-4BDD-9E65-975A2F9926E0Q36014899-F9B61764-BDCC-49A3-98C7-DBA226F86A16Q36089528-F36965E6-7FAE-4C2C-8232-6D71D012EA41Q36470935-986CF433-79D7-4253-93CD-46EF9AEF6BFBQ37325898-83FB55DF-8BDE-4C68-994B-642D414DD178Q37479988-EDB86581-B641-47B7-AD71-35B0B12A68F5Q37699429-800AE1ED-0E3D-4C88-B5DD-3ADC9889777EQ37705561-95BB818B-BB1F-42E8-9563-FFDA0E8F9C29Q37809791-7F00BBBF-6ED3-4E9B-B8FB-2148FAAE3D94Q39388549-527A072C-DE12-4FD5-A4AC-D78C37A0DD45Q43967064-C3189FE9-DAE7-44FC-8BAB-F828C4A058F6Q45813085-02BED8C5-7B65-4571-BAEF-C800EABDEE62Q45855990-86E804F7-81A9-4535-9D13-EA1CDFD9A91EQ45855994-692C27ED-77D0-48C3-A8DA-5205A46FB91AQ45861796-C4D61D0E-2A71-4C3F-82FC-A289DDF91DDEQ45869275-5987BE4A-1594-4A01-9BB8-AD3DC1FDBDBFQ47625297-BC11175A-5A7E-4B7C-B931-6EC98F8F8C2EQ47874270-25737F2E-28F5-44EC-A8E1-1FDDB9C706B3Q49538209-53046A9D-F141-4D51-A087-2D82876D6921Q51598319-E67ECED4-188D-4CD1-B24F-5E1C3759DD5FQ53022037-A6C689D2-0760-4A2E-B840-950DB1FEF893
P2860
Confounding and indication for treatment in evaluation of drug treatment for hypertension.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Confounding and indication for ...... ug treatment for hypertension.
@ast
Confounding and indication for ...... ug treatment for hypertension.
@en
type
label
Confounding and indication for ...... ug treatment for hypertension.
@ast
Confounding and indication for ...... ug treatment for hypertension.
@en
prefLabel
Confounding and indication for ...... ug treatment for hypertension.
@ast
Confounding and indication for ...... ug treatment for hypertension.
@en
P1433
P1476
Confounding and indication for ...... ug treatment for hypertension.
@en
P2093
P304
P356
10.1136/BMJ.315.7116.1151
P407
P577
1997-11-01T00:00:00Z